257 related articles for article (PubMed ID: 30006795)
1. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
[TBL] [Abstract][Full Text] [Related]
2. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
3. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
4. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
6. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
7. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
8. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
9. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
[TBL] [Abstract][Full Text] [Related]
10. Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.
Puvanesarajah S; Gapstur SM; Patel AV; Sherman ME; Flanders WD; Gansler T; Troester MA; Gaudet MM
Breast Cancer Res Treat; 2019 Oct; 177(3):679-689. PubMed ID: 31264062
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.
José Bento M; Gonçalves G; Aguiar A; Antunes L; Veloso V; Rodrigues V
J Med Screen; 2014 Jun; 21(2):104-9. PubMed ID: 24803482
[TBL] [Abstract][Full Text] [Related]
12. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
Parise CA; Caggiano V
Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
[TBL] [Abstract][Full Text] [Related]
13. Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society.
Park S; Moon BI; Oh SJ; Lee HB; Seong MK; Lee S; Byun KD; Jung SP; Bae SY
Breast Cancer Res Treat; 2019 Feb; 173(3):679-691. PubMed ID: 30390214
[TBL] [Abstract][Full Text] [Related]
14. Breast density and breast cancer-specific survival by detection mode.
van der Waal D; Verbeek ALM; Broeders MJM
BMC Cancer; 2018 Apr; 18(1):386. PubMed ID: 29618328
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study.
Musolino A; Falcini F; Sikokis A; Boggiani D; Rimanti A; Pellegrino B; Silini EM; Campanini N; Barbieri E; Zamagni C; Degli Esposti R; Cortesi L; Bisagni G; Cavanna L; Frassoldati A; Sgargi P; Michiara M
Eur J Cancer; 2018 Jan; 88():10-20. PubMed ID: 29175735
[TBL] [Abstract][Full Text] [Related]
16. Differences in Breast Cancer Survival by Molecular Subtypes in the United States.
Howlader N; Cronin KA; Kurian AW; Andridge R
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):619-626. PubMed ID: 29593010
[No Abstract] [Full Text] [Related]
17. Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.
Caumo F; Romanucci G; Hunter K; Zorzi M; Brunelli S; Macaskill P; Houssami N
Breast Cancer Res Treat; 2018 Jul; 170(2):391-397. PubMed ID: 29557996
[TBL] [Abstract][Full Text] [Related]
18. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
19. Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010.
Poiseuil M; Coureau G; Payet C; Savès M; Debled M; Mathoulin-Pelissier S; Amadeo B
Cancer Epidemiol; 2019 Jun; 60():149-155. PubMed ID: 31015096
[TBL] [Abstract][Full Text] [Related]
20. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C; Czene K; Orgeás CC; Hall P
Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
